Jesse Caplan, a Member of the Firm in the Health Care and Life Sciences practice, in the Washington, DC, office, and Serra Schlanger, an Associate in the Health Care and Life Sciences practice, in the Washington, DC, office, cowrote an article titled “Federal Health Insurance Rate Reviews — A Status Report.”
Following is an excerpt:
The Patient Protection and Affordable Care Act (”Affordable Care Act”) required the U.S. Department of Health and Human Services (”HHS”) to establish a process for the review of ”unreasonable” health insurance premium rate increases in the individual and small group markets. As a result, federal regulations mandating the review of all rate increases of 10 percent or more in the individual and small group markets became effective on Sept. 1, 2011.
Reprinted with permission from the Bureau of National Affairs, Inc.